Life-threatening bleeding in a patient with pemphigoid-induced acquired hemophilia A and successfully treated with rituximab and rFVIIa: A case report

RATIONALE: Acquired hemophilia A (AHA) is a rare bleeding disorder with prolonged activated partial thromboplastin time (aPTT). Severe hemorrhage may occur, especially in refractory AHA. PATIENT CONCERNS: We reported a 63-year-old man who suffered from life-threatening bleeding after the onset in lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Hongbing, Chang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837823/
https://www.ncbi.nlm.nih.gov/pubmed/33545998
http://dx.doi.org/10.1097/MD.0000000000024025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837823/
https://www.ncbi.nlm.nih.gov/pubmed/33545998
http://dx.doi.org/10.1097/MD.0000000000024025

Ejemplares similares